fda tirzepatide shortage resolved october 2 2024 declares Mounjaro, Zepbound over Zepbound, Mounjaro shortages are resolved,

Are You Experiencing Side Effects

First, it creates a record that your provider can review

Continued tirzepatide: Lost an additional 5.5% Total weight loss at 88 weeks: 25.3% 89.5% maintained at least 80% of their weight loss Switched to placebo: Regained weight Total weight loss at 88 weeks: 9.9% Only 16.6% maintained at least 80% of their weight loss This trial demonstrates that tirzepatide works best as ongoing treatment and that stopping medication typically leads to significant weight regain

The data from SURMOUNT-4 offers important context

The slowed gut motility that helps with weight loss also slows bowel movements